The objective of this study was to assess the genotypic diversity associated with antimicrobial susceptibility of Salmonella serovars isolated from patients arriving with diarrhoea to six hospitals of Tehran, Iran. During 2007-2008, a cross-sectional convenience study was performed. Stool samples were screened for the presence of Salmonella, serotyped, tested for antimicrobial susceptibility using disk diffusion and examined for the presence of relevant resistance genes and integrons by PCR. A total of 1,120 patients were screened for the presence of Salmonella. Out of 71 Salmonella isolates recovered, the following serovars were identified: 17 Typhi, 14 Paratyphi C, 13 Enteritidis, 11 Paratyphi B, 10 Paratyphi A and six Infantis. Most resistance was observed towards sulfamethoxazole (30%), tetracyclines (25%), nalidixic acid (22%), spectinomycin (17%), trimethoprim (15%), ampicillin (14%) and kanamycin (14%). The tetracycline resistance genes tet(A), tet(B), and tet(G) were found in 28%, 14% and 6% of the tetracycline resistant isolates, respectively. The genes aadA, aadB, strA, strB and aphA1-Iab were present in 83%, 55%, 34%, 1% and 17% of the aminoglycoside resistant isolates, respectively. Additionally, bla (PSE) and bla (TEM) β-lactamase genes were detected in 63% and 18% of the ampicillin-resistant isolates. The 23 sulphonamide resistant isolates harboured sul1 and intI1 genes, typical to class 1 integrons. Nine of these isolates also yielded amplicons for intI2 (class 2 integrons). The presence of multi-drug resistant Salmonella may compromise the successful treatment of enteric infection diseases. The enforcement of strict prescription practices will help to minimise the emergence of resistance.

Research Center for Gastroenterology and Liver Disease Shahid Beheshti University of Medical Science Tehran Iran

Zobrazit více v PubMed

Pak J Biol Sci. 2007 Jan 1;10(1):122-6 PubMed

FEMS Microbiol Lett. 1997 Dec 1;157(1):177-81 PubMed

Vet Microbiol. 2010 Aug 26;144(3-4):493-7 PubMed

Vet Res. 2001 May-Aug;32(3-4):243-59 PubMed

Antimicrob Agents Chemother. 2001 Sep;45(9):2658-61 PubMed

Appl Environ Microbiol. 2001 Jan;67(1):445-8 PubMed

Antimicrob Agents Chemother. 2001 Mar;45(3):723-6 PubMed

Int J Food Microbiol. 2008 Sep 30;127(1-2):162-7 PubMed

Epidemiol Infect. 2012 Jan;140(1):146-9 PubMed

J Antimicrob Chemother. 2005 Mar;55(3):301-5 PubMed

Vet Microbiol. 2000 Jul 3;75(1):73-82 PubMed

J Infect Dev Ctries. 2008 Dec 01;2(6):454-60 PubMed

Int J Antimicrob Agents. 2005 May;25(5):358-73 PubMed

Int J Food Microbiol. 2010 May 30;139 Suppl 1:S3-15 PubMed

Jpn J Infect Dis. 2009 Sep;62(5):368-71 PubMed

Clin Microbiol Infect. 2004 Apr;10(4):272-88 PubMed

Indian J Pathol Microbiol. 2009 Jan-Mar;52(1):52-5 PubMed

Res Microbiol. 2004 Sep;155(7):568-70 PubMed

Euro Surveill. 2009 Mar 12;14(10): PubMed

Bull World Health Organ. 2004 May;82(5):346-53 PubMed

J Clin Microbiol. 2002 Aug;40(8):2813-22 PubMed

Commun Dis Public Health. 2001 Sep;4(3):171-7 PubMed

Antimicrob Agents Chemother. 1995 Jan;39(1):185-91 PubMed

Foodborne Pathog Dis. 2010 May;7(5):515-21 PubMed

J Infect Dev Ctries. 2008 Dec 01;2(6):443-7 PubMed

Mol Cell Probes. 1992 Aug;6(4):271-9 PubMed

Nat Rev Microbiol. 2011 Jan;9(1):9-14 PubMed

Clin Infect Dis. 2010 Mar 15;50(6):882-9 PubMed

Antimicrob Agents Chemother. 2003 Feb;47(2):827-9 PubMed

Antimicrob Agents Chemother. 1999 Dec;43(12):3018-21 PubMed

Mol Cell Probes. 1999 Jun;13(3):213-22 PubMed

Foodborne Pathog Dis. 2010 Jan;7(1):91-5 PubMed

J Infect. 2009 Jan;58(1):21-7 PubMed

East Mediterr Health J. 2006 Nov;12(6):798-803 PubMed

J Antimicrob Chemother. 2003 Oct;52(4):715-8 PubMed

Int J Antimicrob Agents. 2010 May;35(5):492-6 PubMed

Scand J Infect Dis. 2008;40(1):18-23 PubMed

Jpn J Infect Dis. 2008 Jul;61(4):269-73 PubMed

J Am Diet Assoc. 2003 Dec;103(12):1646-9 PubMed